Content about modafinil

September 18, 2012
NewsBytes — Generics, 9/24/12

Generic drug makers Hospira, Sagent Pharmaceuticals and Teva Pharmaceutical Industries have launched generic versions of a chemotherapy drug made by Sanofi, the three companies said last month.


August 10, 2012
Mylan launches generic sleep disorder, bipolar disorder drugs

Mylan has launched a generic drug used to treat sleep disorders, the company said Friday.

June 8, 2012
Mylan settles Provigil suit with Teva

Mylan announced that its subsidiary has resolved all disputes with Teva pertaining to the sale of generic versions of a sleep disorder drug.

April 30, 2012
Mylan to launch generic version of Nuvigil in 2016

Mylan plans to start selling a generic version of a drug for sleep disorders starting in June 2016, under a deal with Teva announced Monday.

April 6, 2012
Par launches generic version of Provigil

Par Pharmaceutical has started shipping its generic version of a drug for sleep disorders, the company said Friday.

April 5, 2012
Teva entitled to exclusivity on Provigil, FDA decides

Teva is the first company to file for a generic version of a drug to treat sleep disorders, the Food and Drug Administration has determined.

March 30, 2012
Teva launches authorized generic sleep disorder drug

Teva Pharmaceutical Industries has launched an authorized generic version of Cephalon's Provigil, used for conditions like shift work sleep disorder and narcolepsy, the company said Friday.

October 10, 2011
FTC clears Teva-Cephalon acquisition deal

The Federal Trade Commission has given Teva Pharmaceutical Industries the green light to acquire Frazer, Pa.-based drug maker Cephalon, but with some restrictions, Teva said.

March 30, 2011
Valeant seeks to buy Cephalon

Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.

October 24, 2010
FDA approves REMS for Nuvigil, Provigil

The Food and Drug Administration has approved risk evaluation and mitigation strategies for two sleep...

March 29, 2010
FTC wins pay-for-delay battle

The Federal Trade Commission’s crusade against patent settlements between branded and generic drug makers moved...

March 29, 2010
Jet lag treatment receives complete response letter

The Food and Drug Administration declined to approve a Cephalon drug as a treatment for...

January 10, 2010
Mylan confirms first-to-file patent challenge for Nuvigil generic

Drug maker Cephalon and its French subsidiary sued generic drug maker Mylan in connection with...

January 5, 2010
Watson seeks FDA approval for sleep disorder treatment

Watson has filed an abbreviated new drug application for the generic version of a sleep...

© 2013 Drug Store News. All Rights Reserved.